Features
The Optimism of Optogenetics
This gene-agnostic category aims to restore visual function by expressing artificial photoreceptors within surviving retinal neurons.
By Lauren M. Ciulla, MD, Thomas A. Ciulla, MD, MBA
Rapid Developments in Geographic Atrophy
Current and emerging GA treatments offer hope to affected patients and demonstrate ongoing innovation in this field.
By Sidra Zafar, MD, Sunir Garg, MD, FACS, FASRS
The Promise of Home Monitoring
Remote surveillance of retinal disease enables patient treatments to align with disease progression rather than a pre-specified clinic visit schedule.
By Eric W. Schneider, MD
Private Equity or Private Practice?
Ophthalmologists from both camps weigh in on the benefits and drawbacks of each practice model.
By Lauren Lee
Departments
Fueled by Passion
Viewpoint from the Editor
When we love what we do, the reward isn't just in the outcome—it's in the doing.
By Lisa K. Feulner, MD, PhD
Leading Across Generations
Best Practices
Communication strategies for an efficient practice
By Christa Shephard, Ally Stemen
How to Code the Novel Treatment for AMD
Coding & Reimbursement
Practice management guidance for photobiomodulation of the retina
By Kevin J. Corcoran, COE, FNAO
The Latest News in Ophthalmology
Quick Hits
A look at the latest news and developments in ophthalmology
Get to Know Internal Linking
Web Marketing Tips and Tricks
It can make or break your practice's website.
By Richard Zimbalist, OD, FAAO
Dr. Shannon Boye
Industry Insider
Atsena Therapeutics’ founder and chief scientific officer discusses her role as CSO, the latest developments with ATSN-101, trends in the ocular gene therapy space, and more.
Welcome to the Hot Seat
Real World Ophthalmology Corner
What to expect during your first 90 days as an attending
By Victoria Wang, MD, MS, Lisa M. Nijm, MD, JD